Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 9,393 | 5,847 | 3,604 | 4,672 | 13,604 |
| Gross Profit | 9,393 | 5,847 | 3,604 | 4,672 | 13,604 |
| Operating Expenses | 69,509 | 67,124 | 63,571 | 62,430 | 63,759 |
| Operating Income | -60,116 | -61,277 | -59,967 | -57,758 | -50,155 |
| Other Income | 1,944 | 2,598 | 3,069 | 3,808 | 3,782 |
| Pre-tax Income | -58,172 | -58,679 | -56,898 | -53,950 | -46,373 |
| Income Tax | 56 | 79 | -135 | 75 | -113 |
| Net Income Continuous | -58,228 | -58,758 | -56,763 | -54,025 | -46,260 |
| Net Income | $-58,228 | $-58,758 | $-56,763 | $-54,025 | $-46,260 |
| EPS Basic Total Ops | -0.54 | -0.56 | -0.55 | -0.57 | -0.48 |
| EPS Basic Continuous Ops | -0.54 | -0.56 | -0.55 | -0.56 | -0.48 |
| EPS Diluted Total Ops | -0.54 | -0.56 | -0.55 | -0.57 | -0.48 |
| EPS Diluted Continuous Ops | -0.54 | -0.56 | -0.55 | -0.56 | -0.48 |
| EBITDA(a) | $-58,009 | $-59,550 | $-58,465 | $-56,690 | $-49,563 |